Setiptiline: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
(One intermediate revision by the same user not shown)
Line 1: Line 1:
'''White dog shaker syndrome''' is a condition that primarily affects small breed, white dogs, such as the [[Maltese (dog)|Maltese]], [[West Highland White Terrier]], and [[Poodle]]. The syndrome is characterized by a sudden onset of rapid, involuntary, side-to-side eye movements, and body tremors. The exact cause of the syndrome is unknown, but it is believed to be related to a dysfunction in the [[central nervous system]].
{{Short description|A tetracyclic antidepressant}}
{{Drugbox
| verifiedfields = changed
| verifiedrevid = 477318123
| image = Setiptiline_2D_structure.svg
| image2 =
| width =
| alt =
| caption = Chemical structure of Setiptiline
}}


==Symptoms==
'''Setiptiline''', also known as '''teciptiline''', is a [[tetracyclic antidepressant]] (TeCA) that was developed in the 1970s. It is primarily used in the treatment of [[depression]] and is known for its unique pharmacological profile.


The primary symptoms of white dog shaker syndrome are rapid, involuntary, side-to-side eye movements, and body tremors. These symptoms can be exacerbated by stress or excitement. Other symptoms may include difficulty walking, head tilt, and in severe cases, seizures.
==Pharmacology==
Setiptiline functions primarily as a [[noradrenergic]] and [[serotonergic]] agent. It acts by inhibiting the reuptake of [[norepinephrine]] and [[serotonin]], which are neurotransmitters involved in mood regulation. This mechanism of action is similar to that of other [[antidepressants]], but Setiptiline is distinct due to its tetracyclic structure.


==Diagnosis==
===Mechanism of Action===
Setiptiline's antidepressant effects are believed to result from its ability to increase the levels of norepinephrine and serotonin in the brain. By preventing the reuptake of these neurotransmitters, Setiptiline enhances their activity in the [[central nervous system]], which can help alleviate symptoms of depression.


Diagnosis of white dog shaker syndrome is primarily based on the clinical signs and the breed of the dog. Other conditions that can cause similar symptoms, such as [[hypoglycemia]], [[vestibular disease]], and [[seizure disorders]], should be ruled out. Diagnostic tests may include a complete blood count, blood chemistry profile, urinalysis, and cerebrospinal fluid analysis.
==Clinical Use==
Setiptiline is prescribed for the treatment of major depressive disorder. It may be used in patients who have not responded to other antidepressants, or in those who experience side effects with other medications. The drug is typically administered orally.


==Treatment==
==Side Effects==
Common side effects of Setiptiline include [[dry mouth]], [[drowsiness]], and [[dizziness]]. Some patients may experience [[weight gain]] or [[constipation]]. As with other antidepressants, there is a risk of [[suicidal thoughts]] in young adults and adolescents, particularly when starting the medication or adjusting the dose.


Treatment for white dog shaker syndrome typically involves the use of medications to control the tremors and eye movements. These may include [[corticosteroids]], [[benzodiazepines]], and [[anticonvulsants]]. In some cases, physical therapy may be recommended to help improve balance and coordination.
==Interactions==
Setiptiline can interact with other medications, particularly those that affect the [[central nervous system]]. It should be used with caution in combination with other antidepressants, [[antipsychotics]], or [[benzodiazepines]]. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.


==Prognosis==
==Related pages==
* [[Antidepressant]]
* [[Tetracyclic antidepressant]]
* [[Norepinephrine]]
* [[Serotonin]]


The prognosis for dogs with white dog shaker syndrome is generally good with appropriate treatment. Most dogs will show improvement within a few days of starting treatment, and many can lead normal lives with ongoing medication.
[[Category:Tetracyclic antidepressants]]
 
[[Category:Antidepressants]]
==See also==
 
* [[Dog health]]
* [[Neurology]]
* [[Veterinary medicine]]
 
[[Category:Dog diseases]]
[[Category:Veterinary medicine]]
[[Category:Neurological disorders in animals]]
 
{{stub}}
<gallery>
File:Setiptiline 2D structure.svg|Setiptiline
</gallery>

Latest revision as of 11:30, 23 March 2025

A tetracyclic antidepressant


Setiptiline
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG


Setiptiline, also known as teciptiline, is a tetracyclic antidepressant (TeCA) that was developed in the 1970s. It is primarily used in the treatment of depression and is known for its unique pharmacological profile.

Pharmacology[edit]

Setiptiline functions primarily as a noradrenergic and serotonergic agent. It acts by inhibiting the reuptake of norepinephrine and serotonin, which are neurotransmitters involved in mood regulation. This mechanism of action is similar to that of other antidepressants, but Setiptiline is distinct due to its tetracyclic structure.

Mechanism of Action[edit]

Setiptiline's antidepressant effects are believed to result from its ability to increase the levels of norepinephrine and serotonin in the brain. By preventing the reuptake of these neurotransmitters, Setiptiline enhances their activity in the central nervous system, which can help alleviate symptoms of depression.

Clinical Use[edit]

Setiptiline is prescribed for the treatment of major depressive disorder. It may be used in patients who have not responded to other antidepressants, or in those who experience side effects with other medications. The drug is typically administered orally.

Side Effects[edit]

Common side effects of Setiptiline include dry mouth, drowsiness, and dizziness. Some patients may experience weight gain or constipation. As with other antidepressants, there is a risk of suicidal thoughts in young adults and adolescents, particularly when starting the medication or adjusting the dose.

Interactions[edit]

Setiptiline can interact with other medications, particularly those that affect the central nervous system. It should be used with caution in combination with other antidepressants, antipsychotics, or benzodiazepines. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Related pages[edit]